英国对辉瑞开出近1.07亿美元罚单，因其哄抬药价格2600%

smilingcloud

英国竞争和市场管理局对辉瑞开出近1.07亿美元罚单，因其哄抬抗癫痫药价格2,600%http://www.reuters.com/article/us-pfizer-britain-fine-idUSKBN13W0VT
[size=1.6em]BUSINESS NEWS [size=1.4em]| [size=1.4em]Wed Dec 7, 2016 | 4:29am EST
Britain fines Pfizer record $107 million for huge drug price hike

[size=1.3em]The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File photo





[size=1.5em]By Ben Hirschler [size=1.5em]| LONDON

[p=24, null, left]Britain's competition watchdog has fined Pfizer (PFE.N) a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent.

[p=24, null, left]The Competition and Markets Authority (CMA) also fined Flynn Pharma 5.2 million pounds for overcharging for phenytoin sodium capsules, following a dramatic price hike in 2012.

[p=24, null, left]The CMA's ruling comes amid a growing debate on both sides of the Atlantic about the ethics of price hikes for old off-patent medicines that are only made by a few firms and where there is little competition.

[p=24, null, left]U.S. drugmaker Turing Pharmaceuticals, led at the time by hedge fund manager Martin Shkreli, caused outrage last year by raising the U.S. price of Daraprim, an old anti-infective drug, by more than 5,000 percent to $750 a pill.

[p=24, null, left]In the case of phenytoin sodium capsules, the UK price charged for 100 mg packs of the drug jumped from 2.83 pounds to 67.50 in 2012, before reducing to 54.00 from May 2014.


[p=24, null, left]As a result, annual spending on the capsules by Britain's National Health Service rose from 2 million pounds in 2012 to about 50 million in 2013. The CMA said UK prices were many times higher than elsewhere in Europe.

[p=24, null, left]Pfizer used to market the medicine under the brand name Epanutin but sold the rights to Flynn, a privately owned British company, in September 2012.

[p=24, null, left]It was then debranded, meaning that it was no longer subject to price regulation, and the price soared.


[p=24, null, left]"The companies deliberately exploited the opportunity offered by debranding to hike up the price for a drug which is relied upon by many thousands of patients," Philip Marsden, chairman of the CMA's case decision group, said on Wednesday.

[p=24, null, left]"This is the highest fine the CMA has imposed and it sends out a clear message to the sector that we are determined to crack down on such behaviour."

[p=24, null, left]Pfizer said in a statement it planned to appeal all aspects of the CMA's verdict.

ALSO IN BUSINESS NEWS

• Exclusive: In mammoth task, BP sends almost three million barrels of U.S. oil to Asia
• Monte dei Paschi bolsters European stocks, ECB looms
  

[p=24, null, left]The U.S. drugmaker said the medicine had been loss-making and it was therefore forced to consider whether it could continue supplying it. Pfizer added that the price set by Flynn was actually 25 to 40 percent less than the cost of an equivalent tablet form from another supplier.

[p=24, null, left]Flynn also plans to appeal. Chief executive David Fakes said punishing Flynn for selling phenytoin capsules for less than phenytoin tablets "beggars belief".

[p=24, null, left]($1 = 0.7903 pounds)



[p=24, null, left](Editing by Jane Merriman/Keith Weir/Alexander Smith)

smilingcloud

伦敦英国竞争监管机构已被罚辉瑞（PFE.N）创纪录的8420万英镑（$ 107万美元）用于其多达2,600％的斜坡高达癫痫药物的成本的作用。

竞争和市场管理局（CMA）在2012年大幅提价之后，也对Flynn Pharma罚款520万英镑用于苯妥英钠胶囊的过量充电。

CMA的裁决是在大西洋两岸关于旧的非专利药物的价格上涨的伦理问题上的日益激烈的辩论，这些专利药物只是由少数几家公司做出，而且几乎没有竞争。

美国制药商Turing Pharmaceuticals在对冲基金经理Martin Shkreli的带领下，去年通过提高Daraprim（一种旧的抗感染药）的美国价格，使其价格超过5000美元，达到750美元。

在苯妥英钠胶囊的情况下，英国对100毫克药物的价格从2012年的2.83磅跃升到67.50，之后从2014年5月降至54.00。

因此，英国国家卫生服务机构胶囊的年度支出从2012年的200万英镑增加到2013年的约5000万英镑。CMA说，英国的价格比欧洲其他地区高出许多倍。

辉瑞公司曾经以Epanutin品牌销售该药，但于2012年9月将权利卖给了一家私营英国公司Flynn。

然后它被取消了名称，意味着它不再受价格管制，价格飙升。

CMA公司案件决策小组主席Philip Marsden周三表示：“这些公司故意利用去标记的机会提高一种药物的价格，这种药物被成千上万的患者所依赖。

“这是CMA实行的最高罚款，它向行业发出了一个明确的信息，我们决心打击这种行为。

辉瑞在一份声明中说，它计划呼吁CMA判决的所有方面。

美国制药商说，这种药物是亏损的，因此被迫考虑是否可以继续供应。 辉瑞补充说，Flynn设定的价格实际上比另一家供应商的同等平板电脑价格低25％至40％。

Flynn也计划上诉。 行政长官大卫·费克斯说，惩罚弗林出售苯妥英胶囊少于phenytoin片“乞求信仰”。

（$ 1 = 0.7903磅）

smilingcloud

帝国主义打起土豪劣绅来一点也不手软啊。  

smilingcloud

[p=30, null, left]制药巨头辉瑞和弗林制药公司在将抗癫痫药物的费用提高达2600%之后，英国卫生部称其定价过高以及不够公平向其开出近9000万英镑的罚单。

[p=30, null, center]

[p=30, null, left]　　竞争与市场管理局(CMA)表示，制药公司辉瑞和经销商弗林制药公司违反了竞争法，他们增加了英国约48000名患者使用的药物的成本。这些特效药的价格上涨已经使纳税人多花费了成千上万英镑。

[p=30, null, left]　　监管者称，辉瑞的这一举动致使英国患者药品支出成本从2012年每年约200万英镑上升到2013年约5000万英镑，这远远超过辉瑞在任何其他欧洲国家的费用。

[p=30, null, left]　　辉瑞公司被罚8420万英镑，而Flynn Pharma被罚款520万英镑。 CMA还命令两家公司降低其抗癫痫药的价格。辉瑞在2012年9月将Epanutin的英国分销权卖给了Flynn制药公司，随后药物被拆除品牌化，这意味着它不再受价格管制的约束。两家公司都提高了药物的价格，这意味着一夜之间用药成本激增了2300%至2600%，药价从2.83英镑的药物价格跳跃从67.50英镑。

MP4

辉瑞是TetraLogic投资方，据闻Birinapant这药效果杠杠的，可惜副作用TetraLogic要解散了，辉瑞估计够伤心的.